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Abstract The length of the published glycoprotein (G)
gene sequences of avian metapneumovirus subtype-C
(aMPV-C) isolated from domestic turkeys and wild birds in
the United States (1996–2003) remains controversial. To
explore the G gene size variation in aMPV-C by the year of
isolation and cell culture passage levels, we examined 21
turkey isolates of aMPV-C at different cell culture pas-
sages. The early domestic turkey isolates of aMPV-C
(aMPV/CO/1996, aMPV/MN/1a-b, and 2a-b/97) had a G
gene of 1,798 nucleotides (nt) that coded for a predicted
protein of 585 amino acids (aa) and showed [97% nt
similarity with that of aMPV-C isolated from Canada
geese. This large G gene got truncated upon serial passages
in Vero cell cultures by deletion of 1,015 nt near the end of
the open reading frame. The recent domestic turkey iso-
lates of aMPV-C lacked the large G gene but instead had a
small G gene of 783 nt, irrespective of cell culture passage
levels. In some cultures, both large and small genes were
detected, indicating the existence of a mixed population of
the virus. Apparently, serial passage of aMPV-C in cell
cultures and natural passage in turkeys in the ﬁeld led to
truncation of the G gene, which may be a mechanism of
virus evolution for survival in a new host or environment.
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Introduction
Avian metapneumovirus (aMPV) is an economically sig-
niﬁcant pathogen of turkeys with a worldwide distribution
[1, 2]. Though the disease caused by aMPV was identiﬁed
in South Africa in late 1970s [3] and in Europe in 1980s [4,
5], the United States was free of aMPV infection until 1996.
An outbreak of upper respiratory tract infection of com-
mercial turkeys in Colorado in May, 1996 resulted in the
isolation of aMPV, for the ﬁrst time in the United States [6].
The aMPV outbreak in Colorado that lasted for 10 months
was eliminated by intense biosecurity measures and has not
been reported since. In Minnesota, the virus was ﬁrst
identiﬁed in 1997 [6] and is still an economic concern to the
turkey industry in the state [7]. Now there is serological
evidence for the spread of aMPV to neighboring states of
North Dakota, South Dakota, Iowa, and Wisconsin [8].
The virus causes an acute upper respiratory tract infection
in turkeys [9–11] and is also involved in the etiology of
swollen head syndrome in chickens [12, 13], although aMPV
has not been detected in chickens in the United States. The
disease caused by aMPV in turkeys is characterized by
coughing, sneezing, nasal discharge, tracheal rales, foamy
conjunctivitis, and swollen sinuses [14]. Uncomplicated cases
have low mortality (2–5%) but infections accompanied by
concurrent secondary bacterial infections can result in up to
25% mortality [9].Inbreederturkeyﬂocks,thereisatransient
drop in egg production and paleness of the eggshell [15].
The aMPV belongs to the genus Metapneumovirus of
the subfamily Pneumovirinae of the family Paramyxovir-
idae [16]. It contains a negative-sense, non-segmented,
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namely, nucleocapsid (N), phosphoprotein (P), matrix (M),
small hydrophobic (SH), surface glycoprotein (G), fusion
(F), second matrix (M2), and RNA-dependent RNA poly-
merase (L) genes in the order 30-le-N-P-M-F-M2-SH-G-L-
tr-50 [17, 18]. In contrast to the members of the genus
Pneumovirus in the subfamily Pneumovirinae, aMPV lacks
the non-structural (NS1 and NS2) genes [16, 19] and has a
smaller L gene than other pneumoviruses [20, 21]. Based
on sequence divergence described in the G gene and anti-
genic differences observed among aMPV strains, the
aMPV isolates are classiﬁed into four subgroups: A, B, C,
and D. The isolates from the United States belong to sub-
group C (aMPV-C), while the strains isolated from other
parts of the world belong to one of the other three sub-
groups [22–24]. Interestingly, sequence analyses have
shown that aMPV-C isolates from the United States are
more closely related to human metapneumovirus (hMPV)
than to their avian counterparts [25–28].
AseasonalpatternintheoccurrenceofaMPV-Chasbeen
observedinMinnesotawithahighrateofincidenceinspring
(ApriltoMay)andautumn(OctobertoDecember)[29].One
of the reasons for the seasonality of aMPV outbreaks in
Minnesotawasspeculatedtobethemigratorypatternofwild
birds that are involved in the transmission of the virus [29].
Recently aMPV-C was isolated from asymptomatic wild
CanadageeseinMinnesotawhichwasshowntobeavirulent
but immunoprotective in domestic turkeys [30]. Genomic
analysis of the goose aMPV-C demonstrated a larger G gene
compared to that of domestic turkey isolates [30].
The G gene of aMPV has been of much scientiﬁc
curiosity owing to its role in host cell attachment and
possible role in virulence and immunity. Extensive
sequence divergence of G gene was observed among
European subtypes of aMPV [24]. The G gene of aMPV-C
from the United States was independently sequenced by
different research groups but the reports on its size and
characteristics were often contradictory to each other [30–
32]. A G gene size of 783 nt or 1321 nt or 1798 nt was
reported by different researchers [30–32]. The reasons for
these differences in the G gene in different isolates and the
possible consequence of this on the evolution of the virus
are not well studied. We speculated that the presence of a
large G gene in aMPV-C isolated from wild birds (Canada
geese) and domestic turkeys in 1996–1997 when they ﬁrst
appeared in the United States, and a small G gene in those
isolated from domestic turkeys after 1997, could be due to
selective pressure. The general hypothesis was that aMPV-
C in domestic turkeys might have originated from wild
birds and that the virus might have lost part of the G gene
upon passage in the turkey population. In the present study
we investigated the nature of the G gene of different
aMPV-C isolates from domestic turkeys and compared that
with the published G gene of aMPV-C from Canada goose
in an attempt to answer the question that whether wild bird
aMPV was a potential progenitor of the virus that is
presently circulating in the domestic turkeys in the United
States. The speciﬁc objective of the present study was to
analyze the G gene of aMPVs isolated from domestic
turkeys from the United States from 1996 to 2003 to
examine any variation in the gene with respect to the time
of isolation from turkeys and passage in cell cultures.
Materials and methods
Viruses
Twenty-one isolates of aMPV-C isolated over a period of
7 years from 1996 to 2003 from the United States (1 from
Colorado and 20 from Minnesota) were used in this study
(Table 1). For convenience, in the text, viruses were des-
ignated as aMPV/CO for the Colorado isolate and as
aMPV/MN followed by a number for those isolated from
Minnesota. All these viruses were isolated from domestic
turkeys following a natural outbreak of aMPV disease in
commercial turkey ﬂocks.
In addition to the above-mentioned isolates, two vaccine
strains of aMPV-C were also used in the study. The vaccine
Table 1 Different isolates of aMPV/C from naturally infected tur-
keys used for the analysis of glycoprotein gene
No. Source County Designated name
1 Turbinate Weld aMPV/Colorado/Turkey/1996
2 Turbinate Becker aMPV/Minnesota/Turkey/1a/1997
3 Tracheal Swab Becker aMPV/Minnesota/Turkey/1b/1997
4 Turbinate Meeker aMPV/Minnesota/Turkey/2a/1997
5 Tracheal Swab Meeker aMPV/Minnesota/Turkey/2b/1997
6 Turbinate Steele aMPV/Minnesota/Turkey/4a/1999
7 Choanal Swab Steele aMPV/Minnesota/Turkey/4b/1999
8 Choanal Swab Steele aMPV/Minnesota/Turkey/4c/1999
9 Choanal Swab Rice aMPV/Minnesota/Turkey/5/1999
10 Turbinate Steele aMPV/Minnesota/Turkey/6/1999
11 Choanal Swab Meeker aMPV/Minnesota/Turkey/7/1999
12 Turbinate Meeker aMPV/Minnesota/Turkey/8/1999
13 Turbinate Meeker aMPV/Minnesota/Turkey/9/1999
14 Turbinate Kandiyohi aMPV/Minnesota/Turkey/10/1999
15 Turbinate Stearns aMPV/Minnesota/Turkey/11/1999
16 Turbinate Meeker aMPV/Minnesota/Turkey/13/2000
17 Turbinate Meeker aMPV/Minnesota/Turkey/14/2001
18 Turbinate Ottertail aMPV/Minnesota/Turkey/16/2000
19 Turbinate Kandiyohi aMPV/Minnesota/Turkey/17/2000
20 Turbinate Kandiyohi aMPV/Minnesota/Turkey/18/2000
21 Choanal Swab Rice aMPV/Minnesota/Turkey/19/2003
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123strain p41 was aMPV/MN 1a serially passaged 41 times in
Vero cells and had been used in a controlled exposure
program for vaccination in Minnesota beginning in August
1999. The second one was p63, which was aMPV/MN 1a
passaged 63 times in Vero cells [33] and is currently a
commercially available licensed aMPV-C vaccine (Pneu-
momune, Biomune Company, Lenexa, KS).
Cells and media
Primary isolation of the virus was done in speciﬁc-patho-
gen-free chicken embryo ﬁbroblasts (CEF). Cells were
grown in Minimum Essential medium (MEM, Invitrogen,
Carlsbad, CA) supplemented with 10% bovine fetal serum,
2m ML-glutamine, non-essential amino acids, 100 IU/ml
of penicillin G sodium, and 100 lg/ml streptomycin sul-
fate. The same medium was used for cell maintenance
except that the bovine fetal serum was reduced to 3%.
Nasal turbinate tissues and/or choanal or tracheal swabs
were collected from infected birds. A 20% homogenate of
the turbinate was prepared in MEM (Invitrogen) supple-
mented with penicillin G sodium 100 IU/ml, streptomycin
sulfate 100 lg/ml, amphotericin B 25 lg/ml, and genta-
micin 150 lg/ml. A 2 ml volume each of the same medium
was used for preparing the swab suspension. The turbinate
homogenate or swab suspension was then fractionated by
centrifugation at 8000 9 g for 10 min. An 80–90% con-
ﬂuent monolayer of CEF in a 25 cm
2 cell culture ﬂask was
inoculated with 1 ml of the sample supernatant and incu-
bated at 37C for 1 h. The cell monolayer was washed with
PBS (pH 7.2), fresh medium was added and incubated at
37C for 3–5 days. Five to seven passages were done in
CEF. The end point was determined by aMPV-C M gene
RT-PCR [34] and indirect immunoﬂuorescent assay [35].
Following primary isolation, viruses were propagated in
Vero cells (ATCC Number: CCL-81) infected at MOI 0.01,
under the same conditions described above. Following each
cell culture passage, the virus was harvested by three
cycles of freezing and thawing. The cell culture suspension
was fractionated by centrifugation at 8000 9 g for 10 min
and the supernatant was aliquoted and stored at -70C.
RT-PCR
The viral mRNA was extracted from nasal turbinate
homogenate, choanal/tracheal swab, CEF or Vero cell cul-
ture supernatant using a commercial viral RNA extraction
kit (Qiagen, Valencia, CA). RT-PCR was performed using a
commercially available one-step RT-PCR kit (Qiagen). A
matrix (M) gene-based aMPV RT-PCR was performed for
diagnosis and conﬁrmation of samples [34]. The forward
primer used was 50-ACAGTGTGTGAGTTAAAAG-30
(M1) starting from base number 335 of the M gene of
aMPV-C. The reverse primer was 50-TGACTTCAGGA
CATATCTC-30 (M2) starting from the M gene base number
754 of aMPV-C (GenBank Accession Number: AF187151).
A set of primers based on the published G gene of
aMPV-C isolated from Canada goose was used [30]t o
examine aMPV-C strains at different CEF and Vero cell
passage levels. The forward primer (50-ACAAGTCAA
CATGGAGGTCA-30) was originally derived from the
consensus G gene sequences of aMPV-Cs isolated from
turkeys and Canada goose (GenBank Accession Numbers:
AY579780; NC007652). The reverse primer (50-GGC
AAGAYCCTATTGCATTG-30) was derived from the 50
end of the L gene of aMPV-C (GenBank Accession
Numbers: AY579780). These primers were expected to
produce a nucleotide sequence size of 1865 bp from
aMPV-C of Canada goose origin and 785 bp from aMPV-
C of domestic turkey origin [30]. The G gene RT-PCR was
performed using a commercially available kit, SuperScript
III one-step RT-PCR with platinum taq (Invitrogen). The
products of RT-PCR were analyzed by electrophoresis on a
1.2% agarose gel and examined using a trans-illuminator.
Sequence analysis of aMPV G gene
The RT-PCR products were gel puriﬁed using a Gel
extraction kit (Qiagen, Valencia, CA) and sequenced
directly with the G gene-speciﬁc primers derived from the
consensus of the published G gene sequences of the goose
and turkey isolates [30, 36]. The puriﬁed DNA products
were also subcloned into a TA cloning vector pCR4-TOPO
(Invitrogen) and transformed in One Shot Escherichia coli
cells (Invitrogen). Transformed E. coli were plated on LB
agar containing 100 lg/ml of ampicillin and 50 lg/ml of
kanamycin and incubated at 37C overnight. Three ran-
domly selected colonies were grown overnight in LB
medium containing 100 lg/ml of ampicillin and 50 lg/ml
of kanamycin. Plasmid extraction was performed using
commercially available QIAprep Spin Miniprep kit
(Qiagen). The prepared plasmids were sequenced with T7
forward and SP6 reverse primers. Sequencing was done at
the BioMedical Genomics Center DNA Sequencing and
Analysis Facility at the University of Minnesota (Saint
Paul, MN). Each clone was sequenced thrice. The DNA
sequences obtained were analyzed using BLAST search
(NCBI data bank) to compare the sequences with the data
bank. The sequences were analyzed using DNA STAR and
MEGA version 3.1 [37]. Sequence comparison was per-
formed by multiple alignment using CLUSTALW of
MEGA 3.1.
RT-PCR and G gene sequencing were independently
repeated in the Southeast Poultry Research Laboratories of
the United States Department of Agriculture for conﬁr-
mation and repeatability of the results.
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Identiﬁcation of two major populations of the G gene
The M gene RT-PCR conﬁrmed all the 21 isolates tested as
aMPV-C. The glycoprotein gene of aMPV-C showed
extensive variations in the size of the RT-PCR products on
agarose gels with respect to the different isolates and their
cell culture passages tested. Of the 21 isolates of aMPV-C
tested (Table 1) at CEF passage level 5 or 6 (only for
aMPV/CO), 5 of them had a large G gene segment of 1.8-
kbp size. The large G gene products were obtained for
aMPV/CO, aMPV/MN 1a, aMPV/MN 1b, aMPV/MN 2a,
and aMPV/MN 2b. All the other 16 isolates (No. 6–21;
Table 1) tested at CEF passage level 5 had a small G gene
product of about 0.8 kbp in size.
The low CEF passage isolates of aMPV/CO (CEF p6),
aMPV/MN 1a (CEF p5), aMPV/MN 2a (CEF p5), and the
most recent isolate, aMPV/MN 19, were further propagated
in Vero cells. The aMPV/CO at passage level CEF p6 lost
the large G gene after 7 passages in Vero cells (Vero p7)
but instead had a small G gene product of 0.8 kbp in size
(Table 2). Similarly, aMPV/MN 1a and aMPV/MN 2a at
passage level CEF p5 showed a truncation in their G gene
after 7 and 13 passages in Vero cells, respectively
(Table 2). On the other hand, aMPV/MN 19 (CEF p5 Vero
7) showed a small G gene similar to its low CEF passage
(aMPV/MN 19 CEF p5) (Table 2).
A few of the randomly selected virus isolates aMPV/MN
4a, aMPV/MN 7, aMPV/MN 9, and aMPV/MN 19 tested at
lower passage level CEF p2 also produced small G gene
product of size similar to their CEF p5 strains (data not
shown).TheRT-PCRproductsofthevaccinestrainsp41and
p61 also lacked the large G gene, but instead had a small G
gene product of size about 0.8 kbp (data not shown).
To verify the above results, two different sets of primers
were also used for RT-PCR ampliﬁcation of the G region
from selected aMPV isolates. One pair of primers annealed
to the end of the SH gene (forward primer) and the
beginning of the L gene (reverse primer) about 270 nts
downstream of the L gene start signal. The second pair of
primers targeted to the SH and G intergenic region (for-
ward primer) and the beginning of the L gene open reading
frame (reverse primer). Both pairs of primers produced
similar results as to what was observed with the G gene-
speciﬁc primers (data not shown).
Table 2 Glycoprotein gene
sizes of different isolates of
avian metapneumovirus subtype
C at different cell culture
passage levels
No. Virus designation Passage level
CEF/Vero
Size of glycoprotein
gene RT-PCR product (kbp)
1a aMPV/Colorado/Turkey/1996 CEFp6 1.8
1b aMPV/Colorado/Turkey/1996 CEFp6; Verop7 0.8
2a aMPV/Minnesota/Turkey/1a/1997 CEFp5 1.8
2b aMPV/Minnesota/Turkey/1a/1997 CEFp5; Verop7 0.8
3 aMPV/Minnesota/Turkey/1b/1997 CEFp5 1.8
4a aMPV/Minnesota/Turkey/2a/1997 CEFp5 1.8
4b aMPV/Minnesota/Turkey/2a/1997 CEFp5; Verop13 0.8
5 aMPV/Minnesota/Turkey/2b/1997 CEFp5 1.8
6 aMPV/Minnesota/Turkey/4a/1999 CEFp5 0.8
7 aMPV/Minnesota/Turkey/4b/1999 CEFp5 0.8
8 aMPV/Minnesota/Turkey/4c/1999 CEFp5 0.8
9 aMPV/Minnesota/Turkey/5/1999 CEFp5 0.8
10 aMPV/Minnesota/Turkey/6/1999 CEFp5 0.8
11 aMPV/Minnesota/Turkey/7/1999 CEFp5 0.8
12 aMPV/Minnesota/Turkey/8/1999 CEFp5 0.8
13 aMPV/Minnesota/Turkey/9/1999 CEFp5 0.8
14 aMPV/Minnesota/Turkey/10/1999 CEFp5 0.8
15 aMPV/Minnesota/Turkey/11/1999 CEFp5 0.8
16 aMPV/Minnesota/Turkey/13/2000 CEFp5 0.8
17 aMPV/Minnesota/Turkey/14/2001 CEFp5 0.8
18 aMPV/Minnesota/Turkey/16/2000 CEFp5 0.8
19 aMPV/Minnesota/Turkey/17/2000 CEFp5 0.8
20 aMPV/Minnesota/Turkey/18/2000 CEFp5 0.8
21a aMPV/Minnesota/Turkey/19/2003 CEFp5 0.8
21b aMPV/Minnesota/Turkey/19/2003 CEFp5; Verop7 0.8
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isolates and cell culture highly adapted variants
Sequencing of the large G gene from low passage aMPV/
CO, aMPV/MN 1a, and aMPV/MN 2a revealed a size of
1798 nt that had a predicted amino acid sequence of 585 aa
in size (Fig. 1). These sequences showed more than 97%
nucleotide similarity and above 90% predicted amino acid
identity with the previously published G gene sequences of
the same isolates (GenBank Accession numbers AY590692
(aMPV/CO), AY590690 (aMPV/MN 1a), and AY590693
(aMPV/MN 2a) [32]; and also the Canada goose isolate of
aMPV-C (GenBank Accession number NC007652) [30].
Two of the small G gene products, aMPV/MN 1a (CEF p5
Vero p7) and aMPV/MN 2a (CEF p5 Vero p13) were
cloned and sequenced, whereas the rest were sequenced
directly from the RT-PCR product. The small G gene
sequence analysis revealed that the gene appeared to be a
truncated product of large G gene with a deletion of 1015-
nt-long segment from the large G gene (underlined area of
Fig. 1). Analysis of the small G gene of high passage
aMPV/MN 1a and aMPV/MN 2a showed a gene size of
783 nt and more than 96% nucleotide similarity with the
ﬁrst 752 nucleotides of their respective large G genes from
the low passage (Fig. 2). Sequence analysis also showed
that clones derived from the same puriﬁed small fragment
of high passage aMPV/MN 1a and aMPV/MN 2a also
appeared to contain a different length of the G gene. Some
of the clones had the same length of G as the published
small G gene (783 nts), but others contained a truncated G
with different lengths of nucleotide deletions (38–325 nts)
internally or at the C terminus when compared with the
published small G. The small G gene sequenced directly
from the RT-PCR products also showed a high level of
nucleotide sequence similarity to the 50 end of that of large
G gene sequences of aMPV/CO (CEF p6), aMPV/MN 1a
(CEF p5), and aMPV/MN 2a (CEF p5).
Discussion
There are various reports on the lengthand characteristicsof
G gene of aMPV-C isolated from the United States [30–32].
Alvarezet al.[31]reported thatthe size ofGgene ofaMPV/
CO was about 1321 nt that encoded a single open reading
frame (ORF) coding for a protein of 435 aa. Another study
indicated that the aMPV/CO G gene had a nucleotide
sequenceof783 ntwithoneORFcodingforapolypeptideof
252 aa [38]. Bennett et al. [30] demonstrated that aMPV-C
isolated from Canada goose had a G gene of 1798 nt long
thatcodedforaproteinof585 aainsize.WhenBennettet al.
[30] analyzed the G gene of aMPV/CO and aMPV/MN 2a,
the RT-PCR product was 783 bp in size which was 1015 bp
lessthanthatoftheGooseviruswiththesamesetofprimers.
Govindarajan et al. [32] reported G gene sequencing of
aMPV/CO, aMPV/MN 1a, and aMPV/MN 2a isolates and
showed that the G gene was 1798 nt long with a predicted
GGGACAAGTCAACATGGAGGTCAAGGTAGAGAATGTTGGCAAGTCACAGGA
GCTTAAAGTTAAAGTCAAGAATTTTATAAAAAGGTCTGATTGCAAGAAAAAA
CTTTTTGCCTTGATTTTAGGCTAGTTAGCTTTGAACTCACTATGAATATAATGC
TGTCTGTCATGTATGTGGAGTCAAATGAGGCCCTAAGTTTATGTAGGATCCAA
GGGACTCCTGCTCCAAGAGATAATAAGAAAAACACAGAAAACGCAACAAAG
GAAACAACACTCCACACAACGACCACAACAAGGGATCCAGAGGTGAGGGAA
ACAAAAACCACCAAGCCCCAGGCCAATGAAGGAGCAACAAACCCAAGCAGG
AACCTCACCACCAAGGGAGACAAACACCAAACGACAAGAGCAACAACAGAG
GCAGAACTGGAAAAACAAAGCAAGCAAACCACAGAGCCAGGCACCAGCACC
CAAAAGCACACCCCCGCAAGGCCAAGCAGCAAATCCCCCACCACAACACAA
GCAACAGCACAACCGACAACACCAACAGCCCCAAAAGCAAGCACAGCACCC
AAGAACAGACAGGCAACAACCAAAAAAAACCGAAACGGACACCACAACAG
CAAGCAGAGCAAGGAACACCAACAACCCCACAGAGACAGCAACAACAACTC
CCAAAGCAACAACAGAAACAGGCAAGGGCAAAGAGGGGCCAACACAGCAC
ACAACCAAAGAACAGCCCGAGACAACAGCACGAGAGACAACAACCCCACAG
CCAAGAAGAACAGCCAGCAGGCCAGCCCCAACAACAAAAATCGAAGAGGAG
GCAGAAACCACCAAAACCAGAACAACCAAAAACACCCAAACAAGCACAGGC
CCACCAAGACCAACAAGAAGCACACCAAGCAAAACAGCGACAGAAAACAAC
AAGAGAACCACAACAACAAAGAGACCGAACACAGCGAGCACAGACAGCAG
ACAACAGACCAGAACAACNGCAGAGCAAGACCAACAAACCCAAACCAGGGC
CAAACCCACCACAAATGGGGCCCACCCGCAAACCACCACCACCCCAGAGCA
CAACACAGACACAACAAACAGCACAAAAGGAAGTCCCAAGGAGGACAAAAC
GACCAGAGACCCCAGCAGCAAAACACCAACCGAGCAAGAGGACGCCAGCAA
GGGAACGGCCGCGGCCAACCCCGGAGGCAGCGCCGAGGCAGACAGGAGAGC
ACCCCCGGCAACCACCCCAACGGGGCGCACCACAGAATCGGCCGCGGGCAC
AACGGGGGACGACAGCGGGGCGGAAACCACAAGACGGAGAAGCGCAGCGG
ACAGACGGCCCACGGGGGGCAGCACAGCAGCGGAGGCCGGGACAGCCCAGA
GCGGACGGGCCACGCCGAAGCAGCCGAGCGGCGGCACGGCAGCAGGGAACA
CTGCACCACCGAACAACGAAAGCAGCGGTCGGGCAGATGCCGCACCAGCAG
AGGAAGCCGGGGTCGGCTCAAGCATCTGGCGAGGGAGACACGTCCGCGGGC
CCTGCAGAGAGAGCGCTCCGGAGCATCCGATGAATCCATGCCTTGGGGACGG
CACTGCACGGACCCGTTCGGATGGTGGAGGGAATTTGCCGGCTGGTTGTTAT
GATAGTGGAGCAGATGGGGTGGTTTGCTGTGGAATTTGTGGAGGCAACTCGT
GTTGTTGCGGGCGAGTAGAGTGCACGTGTGGGGGTGGAGCGGGACTACTATC
CTGCTGCTGTGGCTCATACAACTGGAGTTAGTTCAAGAGCAAGTTAGTTAATT
AAAAA
Fig. 1 Nucleotide sequence of the large G gene of aMPV/C
(sequence of aMPV/MN 1a; CEF p5 that showed a large G gene of
1798 bp in size). The gene start and stop signals are bolded and
italicized. The underlined part of the sequence is the segment that got
truncated upon serial passage in Vero cells
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ofthepresentstudywithregardtotheearlypassagesofthose
isolates.
In the present study, we examined the G gene sequences
of 21 aMPV-C isolates from the United States obtained
from 1996 to 2003 and our results indicated extensive
variations in the size of the G gene with regard to the year
of isolation and passage in cell cultures. Viruses isolated
from domestic turkeys in 1996 and 1997, the early years of
the ﬁrst introduction of aMPV in the United States, had a
large G gene which got truncated upon serial passage in
cell cultures. Viruses isolated from 1999 onward from
domestic turkeys lacked this large G gene but instead
showed a small G gene. In this context, it is interesting to
note that aMPV-C isolated from Canada geese in Minne-
sota in 2001 also had a large G gene. The large gene
segment of aMPV-C isolated from domestic turkeys in
1996 and 1997 was 1798 nt in size which was the same size
as the G gene observed in aMPV isolated from Canada
geese [30]. The above-mentioned isolates shared a nt
similarity of above 97% between each other. Adaptation of
1996 and 1997 isolates from domestic turkeys in cell cul-
tures led to deletion of 1015-nt-long segment from the
1798-nt-long large G gene. On the other hand, aMPV-C
isolates obtained from 1999 onward appear to have lost
their large G gene and instead have smaller G gene, irre-
spective of their cell culture passage level. The large G
gene size showed in the present study is in agreement with
that presented by Govindarajan et al. [32] for turkey
isolates and by Bennett et al. [30] for Canada goose iso-
lates from the United States. Similarly the size of our small
G gene fragment was in agreement with the size of aMPV-
C G gene published by Toquin et al. [38] and Lwamba
et al. [36]. The interesting aspect of the present study is
that the results show that all the contradictory reports on
the size of G gene were probably true in their respective
sense. The present study demonstrated that the large G
gene and small G gene are present in different isolates of
aMPV-C depending on the year of isolation and level of
cell culture passage. The vaccine strains p41 and p63 also
showed a small G gene of 783 nt long with a predicted
polypeptide of 252 amino acids. The vaccine strain p41
was introduced to Minnesota turkeys in August 1999 as
part of a controlled exposure program to protect turkeys
against virulent aMPV challenge. In the present study we
detected a deletion in the large G gene in aMPVs isolated
from April 1999 onward and that excludes the possibilities
of a chance introduction of the G gene truncated virus
through controlled exposure program.
Our study also suggests the possibility of a mixed
population of G gene with varying sizes in aMPV-C.
Multiple bands on the gel appeared to persist even after our
attempt to optimize the thermocycler conditions. A similar
experience with aMPV G gene RT-PCR was also reported
elsewhere when genomic RNA was used to amplify the G
gene [32]. Differences in the size of PCR products were
also observed in the G gene of European subtypes of aMPV
and these differences in size were thought to be due to
variations in the 30 end of the G mRNAs [24].
Extensive variations in the G gene sequence were
observed among the European subtypes and were one of
the determinants of aMPV subtype classiﬁcation [24].
Variations in the size of G gene were also observed in
human respiratory syncytial virus where a large portion of
the coding sequence of G gene was found to be deleted in a
cold-passaged candidate vaccine virus [39]. The ability of
viruses to replicate efﬁciently even after the deletion of G
and SH genes was demonstrated in many viruses including
aMPV [40], hMPV [41], and RSV [39]. Though consid-
erable divergence in the sequence alignment of G gene of
aMPV-C has been reported previously [32], this is the ﬁrst
report of an extensive study of 21 isolates showing a large
deletion in the G gene of aMPV-C in those viruses isolated
since 1999 and upon serial passage of the early isolates
(1996–1997) in cell cultures.
The present study demonstrated that similar to the wild
bird (Canada goose) aMPV isolate, early isolates of aMPV-
C from domestic turkeys had a large gene which got
truncated upon in vitro passage of the virus. Serial passage
in cell culture and possibly, natural passage through spread
of virus in turkey population, led to the deletion of a large
portion of G gene producing a truncated version of the
GGGACAAGTCAACATGGAGGTCAAGGTAGAGAATGTTGGCAAGTCACAGGA
GCTTAAAGTCAAAGTCAAGAATTTTATAAAAAGGTCTGATTGCAAGAAAAAA
CTTTTTGCCTTGATTTTAGGGCTAGTCAGCTTTGAACTCACTATGAATATAAT
GCTGTCTGTCATGTATGTGGAGTCAAATGAGGCCCTAAGTTTATGTAGGATCC
AAGGGACTCCTGCTCCAAGGGATAATAAGACAAACACAGAAAACGCAACAA
AGGAAACAACACTCCACACAACGACCACAACAAGGGATCCAGAGGTGAGGG
AAACAAAAACCACCAAGCCCCAGGCCAATGAAGGAGCAACAAACCCAAGCA
GGAACCTCACCACCAAGGGAGACAAACACCAAACGACAAGAGCAACAACAG
AGGCAGAACTGGAAAAACAAAGCAAACAAACCACAGAGCCAGGCACCAGCA
CCCAAAAGCACACCCCCGCAAGACCAAGCAGCAAATCCCCCACCACAACAC
AAGCAATAGCACAACTGACAACACCAACAACCCCAAAAGCAAGCACAGCAC
CCAAGAACAGACAGGCAACAACCAAAAAAACCGAAACGGACACCACAACAG
CAAGCAGAGCAAGGAACACCAACAACCCCACAGAGACAGCAACAACAACTC
CCAAAGCAACAACAGAAACAGGCAAGAGCAAAGAGGGGCCAACACAGCAC
ACAACCAAAGAACAGCCCGAGACAACAGCAGGAGTTAGTTTAAGAGCAAGT
TAGTTAATTAAAAA
Fig. 2 Nucleotide sequence of small G gene of aMPV/C (sequence
of aMPV/MN 1a; CEF p5; Vero p7 that showed a small G gene of
783 bp in size). The gene start and stop signals are bolded and
italicized
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123original gene. The results also suggest a possible role of
wild birds in the transmission of aMPV in turkeys. The
presence of large and small G gene products may indicate
the existence of a mixed population or a quasispecies of the
virus as part of a virus survival mechanism in turkeys. The
results of this present study warrant further investigation on
the role of wild birds in the transmission of aMPV in tur-
keys in the United States. A detailed study is also indicated
to unravel the genetic mechanism of these variations and its
possible role in virus evolution.
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